Montserrat Laguno Centeno

12PUBLICATIONS
25CO-AUTHORS
Equity and trusts lawNanotoxicology, health and safetyBehavioural epidemiologyEpidemiological methodsDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 11, 2026
Effectiveness, Sex Differences, and Patient Experience in Real-World Use of Long-Acting Cabotegravir and Rilpivirine: Results from a Prospective Study.

|May 07, 2026
Atypical HBV Serological Patterns After Switching to CAB/RPV: Interpretation Within Current Definitions.

|Apr 02, 2026
Optimizing HBV Prevention When Switching to Long-Acting Cabotegravir/Rilpivirine.

Alberto Foncillas, Juan Ambrosioni, Lorena de la Mora

|Mar 04, 2026
Case series of hepatitis C virus infection among HIV pre-exposure prophylaxis (PrEP) users: incidence and behavioural characteristics.

Kathereen Lizeth Rodríguez Sauceda, Nicolás de Loredo, Francisco José Montoya Conesa

|Mar 03, 2026
Prevalence of Active HCV Infection in Spain in 2022 Using Multiparameter Evidence Synthesis.

Christos Thomadakis, Ilias Gountas, Konstantinos Gountas

|Jan 15, 2026
Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles.

Alberto Foncillas, Juan Ambrosioni, Abiu Sempere

Pageof 2

Frequent Collaborators

6 joint publications

Elisa de Lazzari

6 joint publications

Ana Gonzalez-Cordón

6 joint publications

Alberto Foncillas

6 joint publications

Josep Mallolas